J B Chemicals & Pharmaceuticals Share Price

J B Chem & Pharm

CMP as on 18-May-22 15:29

₹ 1,593.40
-23.00 -1.42%

Open

₹ 1,610.00

Turnover (lac)

₹ 390

Prev. Close

₹ 1,616.40

Day's Vol (shares)

₹ 24,458

Day's Range (₹)

₹ 1,592.00
₹ 1,610.00

CMP as on18-May-22 15:29

₹ 1,593.00
-24.6 -1.52%

Open

₹ 1,607.90

Turnover (lac)

₹ 24

Prev. Close

₹ 1,617.60

Day's Vol (shares)

₹ 1,633

Day's Range

₹ 1,593.00
₹ 1,609.15

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 07-Feb-2022 - -
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve (i) unaudited financial results for the quarter ended December 31 2021; and (ii) declaration of Interim dividend if any for the financial year 2021-22 Outcome of meeting of Board of Directors-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 read with circular CIR/CFD/CMD/4/2015 dated September 9, 2015- Declaration of interim dividend of Rs. 8.50 per share of FV Rs. 2 (425%) for FY 2021-2022 Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended December 31, 2021 Outcome of meeting of Board of Directors-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 read with circular CIR/CFD/CMD/4/2015 dated September 9, 2015- Declaration of interim dividend of Rs. 8.50 per share of FV Rs. 2 (425%) for FY 2021-2022 (As Per BSE Announcement Dated on 14.02.2022)
Board Meeting - 26-Jan-2022 - -
Acquisition of a portfolio of brands, for use and commercialization within India, from Sanzyme Private Limited Update on Acquisition of Brands and Related Assets from Sanzyme Private Limited (As Per BSE Announcement Dated on 01/02/2022)
Board Meeting - 01-Nov-2021 - -
Quarterly Results Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended September 30, 2021 (As Per BSE Announcement Dated 11.11.2021)
Board Meeting - 04-Aug-2021 - -
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended on June 30, 2021. Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended June 30, 2021 (As per BSE Announcement Dated on 12/8/2021)
Board Meeting - 04-Jun-2021 - -
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2021 ,inter alia, to consider and approve audited financial statements/annual financial results for the financial year ended on March 31, 2021. Board of Directors of the Company at its meeting to be held on June 14, 2021, would also consider recommendation of final dividend for the financial year 2020-2021. (AS Per BSE Announcement Dated on 08.06.2021) Outcome of meeting of Board of Directors Recommendation of final dividend of Rs. 8 per share of FV Rs. 2 (400%) for FY 2020-21. Requests received from certain promoters and promoter group members for re- classification of status as public. (AS Per BSE Announcement Dated on 14.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity